ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,976.97
-1.13%
US Tech 100
21,079.20
-1.25%
Dow Jones
42,197.79
-1.79%
Brent Oil
73.815
0.00%
Bitcoin
105,555.50
0.09%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) Quote

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
12.03
0.95
(8.57%)
Closed June 14 4:00PM
15 min delayed - Upgrade to Realtime
12.0599
0.0299
(0.25%)
After Hours: 7:59PM
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
12.0599
Bid
12.06
Ask
12.10
Volume
19,687,132
11.51 Day's Range 14.2884
3.42 52 Week Range 20.70
Market Cap
556.051M
Previous Close
11.08
Open
11.955
Last Trade
5
@
12.15
Last Trade Time
Financial Volume
$ 253,977,626
VWAP
12.9007
Average Volume (3m)
2,161,228
Shares Outstanding
46,107,451
Dividend Yield
-
PE Ratio
-4.39
Earnings Per Share (EPS)
-2.75
Revenue
90.4M
Net Profit
-126.87M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.urogen.com
Headquarters
Ra'anana, Center, Isr
Founded
-
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $11.08. Over the last year, UroGen Pharma shares have traded in a share price range of $ 3.42 to $ 20.70.

UroGen Pharma currently has 46,107,451 shares outstanding. The market capitalization of UroGen Pharma is $510.87 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -4.39.

Ask ADVFN Intelligence (AI)

UroGen Pharma (URGN) Options Flow Summary

URGN Options Flow

Overall Flow

Bullish

Net Premium

4M

Calls / Puts

3,500.00%

Buys / Sells

146.43%

OTM / ITM

7.46%

Sweeps Ratio

2.78%

URGN Latest News

More News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
June 13 2025
URGN (8.57%)

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2025
URGN (8.57%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 11 2025
URGN (8.57%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 10 2025
URGN (8.57%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.7299126.2645403385.3312.55.23103461148.8008506CS
43.309937.82742857148.7512.53.4254813407.05508929CS
120.16991.4289318755311.8912.53.4221612287.7471007CS
260.62995.5109361329811.4312.53.4212482138.20632335CS
52-0.8101-6.2944832944812.8720.73.4293518710.34805741CS
1565.549985.25192012296.5124.133.4247933411.87997017CS
260-13.3201-52.482663514625.3830.893.4234687612.6663385CS

URGN - Frequently Asked Questions (FAQ)

What is the current UroGen Pharma share price?
The current share price of UroGen Pharma is $ 12.0599
How many UroGen Pharma shares are in issue?
UroGen Pharma has 46,107,451 shares in issue
What is the market cap of UroGen Pharma?
The market capitalisation of UroGen Pharma is USD 510.87M
What is the 1 year trading range for UroGen Pharma share price?
UroGen Pharma has traded in the range of $ 3.42 to $ 20.70 during the past year
What is the PE ratio of UroGen Pharma?
The price to earnings ratio of UroGen Pharma is -4.39
What is the cash to sales ratio of UroGen Pharma?
The cash to sales ratio of UroGen Pharma is 6.16
What is the reporting currency for UroGen Pharma?
UroGen Pharma reports financial results in USD
What is the latest annual turnover for UroGen Pharma?
The latest annual turnover of UroGen Pharma is USD 90.4M
What is the latest annual profit for UroGen Pharma?
The latest annual profit of UroGen Pharma is USD -126.87M
What is the registered address of UroGen Pharma?
The registered address for UroGen Pharma is 9 HATAASIYA ST, PO BOX 2397, RA'ANANA, CENTER, 4365007
What is the UroGen Pharma website address?
The website address for UroGen Pharma is www.urogen.com
Which industry sector does UroGen Pharma operate in?
UroGen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
RBNERobin Energy Ltd
$ 13.85
(313.43%)
101.81M
OPOceanPal Inc
$ 1.63
(125.45%)
80.28M
LGHLWLion Group Holding Ltd
$ 0.0052
(116.67%)
6.87M
NEONNeonode Inc
$ 16.83
(68.47%)
4.78M
ICONIcon Energy Corporation
$ 2.90
(62.01%)
59.04M
SBETSharpLink Gaming Inc
$ 9.2275
(-71.63%)
41.92M
AIHSSenmiao Technology Ltd
$ 0.381
(-63.01%)
16.8M
CHSNChanson International Holding
$ 0.22
(-60.00%)
15.15M
KWMK Wave Media Ltd
$ 2.91
(-50.43%)
2.59M
JZXNJiuzi Holdings Inc
$ 1.56
(-46.39%)
2.24M
HCTIHealthcare Triangle Inc
$ 0.0201
(-33.00%)
856.89M
GNLNGreenlane Holdings Inc
$ 0.0101
(-34.42%)
792.34M
CGBSCrown LNG Holdings Ltd
$ 0.1104
(31.43%)
788.42M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.655
(3.81%)
246.13M
NVDANVIDIA Corporation
$ 141.97
(-2.09%)
180.81M

Discussion

View Full Feed
HyGro HyGro 5 minutes ago
So why wouldn't NWBO filed an application for commercial approval with the FDA?? There's no real profit potential in the UK. U.S. is the only market that oncology treatments make money. Yes, FDA is aware of NWBO as it has to approve the trials and protocols. That also how the FDA is aware that
NWBO
236T568 236T568 7 minutes ago
San Diego today
https://vt.tiktok.com/ZSkCXVpAp/
hap0206 hap0206 9 minutes ago
you poor lost soul

And you fuckwit, every one interested and of objective mind, agrees that Trump has elevated political violence in the USA

so he enforces the laws of this land and riots break out across the nation -- who is doing the violence ??

Mid-ter
uber darthium uber darthium 10 minutes ago
I have been restricted to 3 posts a day because I criticized the operations of ihub. So if I don’t answer it’s because I am saving my posts or I have run out of posts for the day. When this changes is up to you know who admin ihub though I seriously believe she wants me off ihub and has for years.
blackcat blackcat 11 minutes ago
Think so. There are no photos from anywhere showing big crowds.
jjjjjjjj jjjjjjjj 13 minutes ago
https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1ckpspw*_gcl_au*MTI2NDMxNTM2NC4xNzQxNzY4MDk0

51M shares traded today. Up or down or sideway??? It is a damn if you do and damn if you don’t situation. More sells at $0.0002 than buys, or i
MJNA
hap0206 hap0206 17 minutes ago
MY goodness -- so sorry -- of course zab did not mean Trump did it -- how could I have misjudged his post
=====/
zab

Re: hap0206 post# 529735

A couple of Democrats were assassinated today, all part of Trump's military day.

https://investorsh
midnighttoker midnighttoker 18 minutes ago
https://www.modalai.com/pages/us-drone-manufacturers-comprehensive-list?srsltid=AfmBOoowGpVYTuDDrtErrmSlU0cpTsIH1jKtj2UL64RdPN_EjNlhjQLB
CYBL
4retire 4retire 18 minutes ago
The vote in 2024 was to keep us from getting delisted as our pps was very low back then. Who knew the company thought this was in perpetuity? Yes, this was a very low blow for existing shareholders. It certainly makes one wonder about the ethics of KULR’s current management.

Sorry
KULR
Nukemtiltheyglow Nukemtiltheyglow 19 minutes ago
When the words... "according to some studies, Vascepa "may" slightly raise LDL? WHO's studies (Nissen?) and may is not  I know Vascepa doesn't lower LDL if at all. So, the point being from Roonie Toon? 
AMRN
canthelpit canthelpit 22 minutes ago
OZZ MAN That is the gold ,, silver was a primary as well then as a secondary there is copper ,, then bonus REE very exciting !! GLTA
DTREF
Ronak45 Ronak45 25 minutes ago
You didn't give my answer . Who sold 200 million on Friday. If management are genuine and marger is big as you meantion. Why most of people are not buying. Don't manipulate here. Why it will drop to. 0.017 to 0.0001 . One day it will zero bid and RS.
AFFU
blackhawks blackhawks 26 minutes ago
Gov. Walz, Rep. Omar among dozens of Minnesota Democrats on gunman's list: Sources
Source: ABC News

June 14, 2025, 2:21 PM


Dozens of Minnesota Democrats were on a target list written by the gunman who allegedly shot and killed a state representative and s
jay14 jay14 26 minutes ago
Hold on to your satellites....What if Big Time gamer Elon Musk who setting up gaming for a virtual space entered the field and suddenly things start to unravel, everything he touches turns to gold....You can check out his latest coin which could very well be his next IPO....Starlink satellites alrea
TMMI

Your Recent History

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads